355
Participants
Start Date
August 5, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
Deuruxolitinib
Deuruxolitinib will be dosed orally as tablets at a dose of 8 mg
Placebo
Deuruxolitinib matching placebo will be dosed orally as tablets
RECRUITING
Vitality Clinical Trials, Woodbury
NOT_YET_RECRUITING
Dermatology Associates Of Plymouth Meeting, Plymouth Meeting
NOT_YET_RECRUITING
U.S. Dermatology Partners - Rockville, Rockville
NOT_YET_RECRUITING
Djl Clinical Research, Pllc, Charlotte
NOT_YET_RECRUITING
Medical University Of South Carolina: Dermatology Clinic - Rutledge Tower Location, Charleston
RECRUITING
Skin Care Physicians Of Georgia, Macon
NOT_YET_RECRUITING
Solutions Through Advanced Research, Inc., Jacksonville
NOT_YET_RECRUITING
International Clinical Research Us Llc - Sanford, Sanford
NOT_YET_RECRUITING
Pediatric Skin Research Llc, Coral Gables
NOT_YET_RECRUITING
Lenus Research & Medical Group Llc., Sweetwater
NOT_YET_RECRUITING
Total Skin And Beauty Dermatology Center, Birmingham
NOT_YET_RECRUITING
Dawes Fretzin Clinical Research Group Llc., Indianapolis
NOT_YET_RECRUITING
Oakland Hills Dermatology, Auburn Hills
NOT_YET_RECRUITING
Boeson Research Mso, Missoula
NOT_YET_RECRUITING
University Of Utah Health - Dermatology At Midvalley Health Center, Murray
NOT_YET_RECRUITING
Avacare - Cct Research - Springville Dermatology, Springville
NOT_YET_RECRUITING
Dermatology Research Associates, Los Angeles
NOT_YET_RECRUITING
Paradigm Clinical Research - San Diego, San Diego
NOT_YET_RECRUITING
Alberta Dermasurgery Centre, Edmonton
NOT_YET_RECRUITING
Care Clinic Ltd., Red Deer
NOT_YET_RECRUITING
Universite De Montreal-Centre Hospitalier Universitaire Sainte-Justine, Montreal
NOT_YET_RECRUITING
Centre De Recherche Saint-Louis, Québec
Sun Pharmaceutical Industries, Inc.
INDUSTRY